Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereof
The present invention relates to a solid form of 5-((2-ethynyl-5-isopropylpyridin-4-yl)oxy)pyrimidine-2,4-diamine or a hydrate thereof, a method for preparing the solid form, a pharmaceutical composition comprising the solid form, and a use of the solid form for the prevention or treatment of a dise...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LIU, KAI CHENG, CHEUNG-LING ZHOU, LI-YING HUANG, HUAI WANG, HONG-JUN FU, SHEN-ZHEN TIAN, NA-NA CHEN, XIAO PANG, JIAN-MEI MENG, JIE LIU, YA-NAN ZHAO, YAN-PING FENG, ZE-WANG LIU, XUE-LIAN |
| description | The present invention relates to a solid form of 5-((2-ethynyl-5-isopropylpyridin-4-yl)oxy)pyrimidine-2,4-diamine or a hydrate thereof, a method for preparing the solid form, a pharmaceutical composition comprising the solid form, and a use of the solid form for the prevention or treatment of a disease modulated by P2X3 and/or P2X2/3 receptor antagonists. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW202241864A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW202241864A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW202241864A3</originalsourceid><addsrcrecordid>eNqNjLEKwkAQRNNYiPoPax9BzxBsRRR7A5Zhye2Rhbvb9XIW-XsDyQdYDcy8N-vi8xLPFpykAOLAMgaOomPiwJYjQSdB5RstSIJ-tAkzQe4pkbgSNJHiVLFECJR7sfM23ZWAk4SqnrsZWKxtsXLoB9otuSn2j3tzex5IpaVBsaNIuW3e5mhMdbrU1fX8D_MD-7xEeg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereof</title><source>esp@cenet</source><creator>LIU, KAI ; CHENG, CHEUNG-LING ; ZHOU, LI-YING ; HUANG, HUAI ; WANG, HONG-JUN ; FU, SHEN-ZHEN ; TIAN, NA-NA ; CHEN, XIAO ; PANG, JIAN-MEI ; MENG, JIE ; LIU, YA-NAN ; ZHAO, YAN-PING ; FENG, ZE-WANG ; LIU, XUE-LIAN</creator><creatorcontrib>LIU, KAI ; CHENG, CHEUNG-LING ; ZHOU, LI-YING ; HUANG, HUAI ; WANG, HONG-JUN ; FU, SHEN-ZHEN ; TIAN, NA-NA ; CHEN, XIAO ; PANG, JIAN-MEI ; MENG, JIE ; LIU, YA-NAN ; ZHAO, YAN-PING ; FENG, ZE-WANG ; LIU, XUE-LIAN</creatorcontrib><description>The present invention relates to a solid form of 5-((2-ethynyl-5-isopropylpyridin-4-yl)oxy)pyrimidine-2,4-diamine or a hydrate thereof, a method for preparing the solid form, a pharmaceutical composition comprising the solid form, and a use of the solid form for the prevention or treatment of a disease modulated by P2X3 and/or P2X2/3 receptor antagonists.</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221101&DB=EPODOC&CC=TW&NR=202241864A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221101&DB=EPODOC&CC=TW&NR=202241864A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LIU, KAI</creatorcontrib><creatorcontrib>CHENG, CHEUNG-LING</creatorcontrib><creatorcontrib>ZHOU, LI-YING</creatorcontrib><creatorcontrib>HUANG, HUAI</creatorcontrib><creatorcontrib>WANG, HONG-JUN</creatorcontrib><creatorcontrib>FU, SHEN-ZHEN</creatorcontrib><creatorcontrib>TIAN, NA-NA</creatorcontrib><creatorcontrib>CHEN, XIAO</creatorcontrib><creatorcontrib>PANG, JIAN-MEI</creatorcontrib><creatorcontrib>MENG, JIE</creatorcontrib><creatorcontrib>LIU, YA-NAN</creatorcontrib><creatorcontrib>ZHAO, YAN-PING</creatorcontrib><creatorcontrib>FENG, ZE-WANG</creatorcontrib><creatorcontrib>LIU, XUE-LIAN</creatorcontrib><title>Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereof</title><description>The present invention relates to a solid form of 5-((2-ethynyl-5-isopropylpyridin-4-yl)oxy)pyrimidine-2,4-diamine or a hydrate thereof, a method for preparing the solid form, a pharmaceutical composition comprising the solid form, and a use of the solid form for the prevention or treatment of a disease modulated by P2X3 and/or P2X2/3 receptor antagonists.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjLEKwkAQRNNYiPoPax9BzxBsRRR7A5Zhye2Rhbvb9XIW-XsDyQdYDcy8N-vi8xLPFpykAOLAMgaOomPiwJYjQSdB5RstSIJ-tAkzQe4pkbgSNJHiVLFECJR7sfM23ZWAk4SqnrsZWKxtsXLoB9otuSn2j3tzex5IpaVBsaNIuW3e5mhMdbrU1fX8D_MD-7xEeg</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>LIU, KAI</creator><creator>CHENG, CHEUNG-LING</creator><creator>ZHOU, LI-YING</creator><creator>HUANG, HUAI</creator><creator>WANG, HONG-JUN</creator><creator>FU, SHEN-ZHEN</creator><creator>TIAN, NA-NA</creator><creator>CHEN, XIAO</creator><creator>PANG, JIAN-MEI</creator><creator>MENG, JIE</creator><creator>LIU, YA-NAN</creator><creator>ZHAO, YAN-PING</creator><creator>FENG, ZE-WANG</creator><creator>LIU, XUE-LIAN</creator><scope>EVB</scope></search><sort><creationdate>20221101</creationdate><title>Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereof</title><author>LIU, KAI ; CHENG, CHEUNG-LING ; ZHOU, LI-YING ; HUANG, HUAI ; WANG, HONG-JUN ; FU, SHEN-ZHEN ; TIAN, NA-NA ; CHEN, XIAO ; PANG, JIAN-MEI ; MENG, JIE ; LIU, YA-NAN ; ZHAO, YAN-PING ; FENG, ZE-WANG ; LIU, XUE-LIAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW202241864A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LIU, KAI</creatorcontrib><creatorcontrib>CHENG, CHEUNG-LING</creatorcontrib><creatorcontrib>ZHOU, LI-YING</creatorcontrib><creatorcontrib>HUANG, HUAI</creatorcontrib><creatorcontrib>WANG, HONG-JUN</creatorcontrib><creatorcontrib>FU, SHEN-ZHEN</creatorcontrib><creatorcontrib>TIAN, NA-NA</creatorcontrib><creatorcontrib>CHEN, XIAO</creatorcontrib><creatorcontrib>PANG, JIAN-MEI</creatorcontrib><creatorcontrib>MENG, JIE</creatorcontrib><creatorcontrib>LIU, YA-NAN</creatorcontrib><creatorcontrib>ZHAO, YAN-PING</creatorcontrib><creatorcontrib>FENG, ZE-WANG</creatorcontrib><creatorcontrib>LIU, XUE-LIAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LIU, KAI</au><au>CHENG, CHEUNG-LING</au><au>ZHOU, LI-YING</au><au>HUANG, HUAI</au><au>WANG, HONG-JUN</au><au>FU, SHEN-ZHEN</au><au>TIAN, NA-NA</au><au>CHEN, XIAO</au><au>PANG, JIAN-MEI</au><au>MENG, JIE</au><au>LIU, YA-NAN</au><au>ZHAO, YAN-PING</au><au>FENG, ZE-WANG</au><au>LIU, XUE-LIAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereof</title><date>2022-11-01</date><risdate>2022</risdate><abstract>The present invention relates to a solid form of 5-((2-ethynyl-5-isopropylpyridin-4-yl)oxy)pyrimidine-2,4-diamine or a hydrate thereof, a method for preparing the solid form, a pharmaceutical composition comprising the solid form, and a use of the solid form for the prevention or treatment of a disease modulated by P2X3 and/or P2X2/3 receptor antagonists.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_TW202241864A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T17%3A14%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LIU,%20KAI&rft.date=2022-11-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW202241864A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |